Real-world use and effectiveness of adjuvant trastuzumab in 2665 consecutive breast cancer patients

被引：0
|
作者：
Tjan-Heijnen, V. C. G.
Seferina, S. C.
Lobbezoo, D. J. A.
Voogd, A. C.
Dercksen, M. W.
van den Berkmortel, F.
van Kampen, R. J. W.
van de Wouw, A. J.
Joore, M. A.
Borm, G. F.
机构：
[1] Maastricht Univ, Med Ctr, NL-6200 MD Maastricht, Limburg, Netherlands
[2] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, NL-6200 MD Maastricht, Limburg, Netherlands
[3] Maxima Med Ctr, Veldhoven, Brabant, Netherlands
[4] Atrium Med Ctr Parkstad, Heerlen, Limburg, Netherlands
[5] Orbis Med Ctr, Sittard Geleen, Limburg, Netherlands
[6] VieCuri Med Ctr, Venlo, Limburg, Netherlands
[7] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Gelderland, Netherlands
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/0008-5472.SABCS-12-P5-21-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-21-04
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer
    Tarantini, Luigi
    Cioffi, Giovanni
    Gori, Stefania
    Tuccia, Fausto
    Boccardi, Lidia
    Bovelli, Daniella
    Lestuzzi, Chiara
    Maurea, Nicola
    Oliva, Stefano
    Russo, Giulia
    Faggiano, Pompilio
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (02) : 113 - 119
  • [2] Long-Term Safety and Real-World Effectiveness of Trastuzumab in Breast Cancer
    Mazzotta, Marco
    Krasniqi, Eriseld
    Barchiesi, Giacomo
    Pizzuti, Laura
    Tomao, Federica
    Barba, Maddalena
    Vici, Patrizia
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (02)
  • [3] Assessing the Real-World Cost-Effectiveness of Adjuvant Trastuzumab in HER-2/neu Positive Breast Cancer
    Hedden, Lindsay
    O'Reilly, Susan
    Lohrisch, Caroline
    Chia, Stephen
    Speers, Caroline
    Kovacic, Laurel
    Taylor, Suzanne
    Peacock, Stuart
    ONCOLOGIST, 2012, 17 (02): : 164 - 171
  • [4] TRASTUZUMAB THERAPY FOR EARLY BREAST CANCER IN THE REAL-WORLD
    Marla, S.
    Cooke, T. G.
    Roxburgh, P.
    Burton, P.
    Mallon, E.
    Stallard, S.
    Canney, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 85 - 86
  • [5] Real-Life Use and Effectiveness of Adjuvant Trastuzumab in Early Breast Cancer Patients: A Study of the Southeast Netherlands Breast Cancer Consortium
    Seferina, Shanly C.
    Lobbezoo, Dorien J. A.
    de Boer, Maaike
    Dercksen, M. Wouter
    van den Berkmortel, Franchette
    van Kampen, Roel J. W.
    van de Wouw, Agnes J.
    de Vries, Bart
    Joore, Manuela A.
    Peer, Petronella G. M.
    Voogd, Adri C.
    Tjan-Heijnen, Vivianne C. G.
    ONCOLOGIST, 2015, 20 (08): : 856 - 863
  • [6] The real-world cost-effectiveness of adjuvant trastuzumab in HER-2/neu-positive early breast cancer in Taiwan
    Lang, Hui-Chu
    Chen, Hsiao-Wei
    Chiou, Tzeon-Jye
    Chan, Agnes L. F.
    JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (10) : 923 - 927
  • [7] A national real-world prospective study to assess the effectiveness of adjuvant trastuzumab-dkst in HER2 breast cancer.
    Alves, Leandro Ladislau
    Faco, Lara Lopes
    Cardoso, Ana Carolina
    Alcantara, Alexandre
    Figueiredo, Augusto Theodoro
    Rodrigues, Rafaella
    Gandufe, Fatima
    Silva, Fernanda Cristina
    Castilho, Vivienne Carduz
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Real-world data on adjuvant bisphosphonate use in a breast cancer center in Mexico.
    Pena-Curiel, Omar
    Villarreal-Garza, Cynthia
    Diaz-Perez, Hector
    Martinez Trevino, Enrique Francisco
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Trastuzumab related cardiotoxicity in nonmetastatic breast cancer: A real-world scenario
    Shrivastva, S.
    Prasad, S. K.
    Chennamaneni, R.
    Stalin, B.
    Konatam, M. L.
    Gundeti, S.
    ANNALS OF ONCOLOGY, 2019, 30
  • [10] Real-world experience of abemaciclib for adjuvant and metastatic breast cancer
    Drowne, Taylor
    Armgardt, Emily
    Svoboda, Alison
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2025, 31 (01) : 141 - 146
12345